Balancing safety and efficacy involves a multi-faceted approach. It includes rigorous pre-clinical and clinical testing, adherence to regulatory guidelines, and ongoing post-market surveillance. Innovations such as green nanotechnology aim to develop safer nanomaterials by minimizing hazardous substances and utilizing environmentally benign processes.
